Skip to main content
Equibles
BNTC logo

BNTC · Benitec Biopharma Inc.

Track BNTC — free

Use BNTC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about BNTC

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$13.01 -0.37 (-2.77%) At close · Aug 20
Market Cap
$446.95M
Shares
34.35M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.01 Open$13.27 Day$12.37–13.27 52W close$10.06–16.52 Avg vol 30d142K Short int2.1M · 6.2% float · 26.7d Short vol83% Last earningsMay 14, 2026 DataJul 2023–Aug 2026 Filing10-Q · May 14

Raw chart and full-history price indicators begin at the captured split on Jul 26, 2023; bars on opposite sides are not compared.

Up next

FQ1-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 14, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +7%
above
Price vs 50-day avg +4%
above
RSI (14) 54
neutral
MACD trend Positive
52-week position 46%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Strong
1-month return +14%
trailing
6-month return +19%
trailing
YTD return −3%
this year
Relative strength +8%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $13 › 200d $12 — 50d above 200d
Institutional flow Distributing
-2% holders QoQ · +12 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
6.25% of float · ▼ -5.4% MoM · 26.7 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
86 holders — near 3-yr high, broad support
Squeeze score 65
elevated · 0–100
Fundamentals
Fair
Revenue growth −42%
Y/Y
EPS growth +14%
Y/Y
Free cash flow $-23.6M
Balance sheet $97.7M
net cash
Quant / Vol
risk profile
Very High
Volatility 58%
annualized · 1-yr
Max drawdown −39%
past year
ATR 6.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+7% Bullish
Price vs 50-day avg
+4% Bullish
RSI (14)
54 Neutral
MACD trend
Positive Bullish
52-week position
46% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $13 › 200d $12 — 50d above 200d
Institutional flow Distributing
-2% holders QoQ · +12 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
6.25% of float · ▼ -5.4% MoM · 26.7 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
86 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $10 Now $13 · 46% Range high $17
vs 200-day avg +7% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BNTC
Benitec Biopharma Inc.
this stock
$446.95M -3.4% -42.2% — 6.2%
ONC
BeOne Medicines Ltd.
 $557.05B +21.5% +22179.2% 856.5 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $136.93B +19.2% +46.2% 31.5 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $86.39B +7.1% +20.8% 20.8 3.3%
MRNA
Moderna, Inc.
 $69.62B +352.1% +4.3% — 12.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
86
% held
96.5%
Net QoQ
+746.0K sh
Top holder
SUVRETTA CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
87
View
Short & Settlement
Short Interest Falling
Shares short
2.1M
Days to cover
26.7d
Change
-123.0K sh
View
Short Volume
Short vol %
83%
As of
Aug 20, 2026
Short Total
View
Fails to Deliver
FTD shares
233
Value
$2.8K
As of
Jul 29, 2026
View
Off-Exchange
Off-exchange %
31.6%
Week of
Jul 13, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$59.0K
Net income (FY)
$-37.9M
EPS diluted
$-1.05
View
Filings
SEC Filings
Latest
8-K
Filed
May 29, 2026
This year
6
View
Exempt Offerings
Offering
$40.0M
Filed
Apr 25, 2024
View
Earnings & Events
Earnings Calls
Last call
May 14, 2026
View

Performance

Raw-price comparisons begin at the captured split on Jul 26, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
BNTC +3.6% +13.7% +19.4% +11.1% -3.4%
SPY -2.0% +3.3% +11.2% +2.1% +11.8%
vs SPY +5.5% +10.4% +8.2% +9.0% -15.2%
Key facts CIK 1808898 CUSIP 08205P209 13F (30d) 82 filings 82 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)